ClinicalTrials.Veeva

Menu

PRognOstiC valuE of rEd Density in Ulcerative Colitis (PROCEED-UC)

U

Universitaire Ziekenhuizen KU Leuven

Status

Completed

Conditions

Ulcerative Colitis

Treatments

Diagnostic Test: Red Density

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Observational prospective multicenter study: baseline assessement of the disease activity by an automated endoscopic tool and follow up of 52 weeks to evaluate sustained clinical remission.

Enrollment

243 patients

Sex

All

Ages

16+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Confirmed diagnosis of UC for at least 3 months
  • Clinical remission with SCCAI <3 at baseline and stable remission for the last 3 months
  • Ability to give informed consent by the patient or legal representative in case of minority.

Exclusion criteria

  • Any contraindication for sigmoidoscopy or undergoing biopsies of the rectosigmoid.
  • Uncontrolled coagulopathy.
  • Any planned change in UC related treatment (both escalation and de-escalation) after the baseline endoscopy
  • Planned UC related surgery
  • Previous subtotal or total colectomy
  • Short bowel, ileostomy or colostomy
  • Pregnancy at baseline
  • Age younger than 16 years

Trial design

243 participants in 1 patient group

Ulcerative colitis in clinical remission
Description:
Clinical remission with SCCAI \<3 at baseline and stable remission for the last 3 months
Treatment:
Diagnostic Test: Red Density

Trial contacts and locations

2

Loading...

Central trial contact

Chelsea Camps; Peter Bossuyt, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems